SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-026638
Filing Date
2022-12-16
Accepted
2022-12-16 08:38:15
Documents
16
Period of Report
2022-12-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K celu-20221216.htm   iXBRL 8-K 62120
2 EX-99.1 celu-ex99_1.htm EX-99.1 27796
3 GRAPHIC img173972250_0.jpg GRAPHIC 8768
4 GRAPHIC img173972250_1.jpg GRAPHIC 4089
  Complete submission text file 0000950170-22-026638.txt   267162

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celu-20221216.xsd EX-101.SCH 3461
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celu-20221216_pre.xml EX-101.PRE 14181
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celu-20221216_lab.xml EX-101.LAB 17766
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celu-20221216_def.xml EX-101.DEF 14174
10 EXTRACTED XBRL INSTANCE DOCUMENT celu-20221216_htm.xml XML 6500
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 221466554
SIC: 2834 Pharmaceutical Preparations